ASX/BIO (ASX/BIO)

Australian Securities Exchange: ASX/BIO · AUD

A$0.36

-0.01 (-1.4%)· Recorded snapshot

Market cap	82.1M
Revenue (ttm)	23.9M
Net income (ttm)	3.6M
EPS (ttm)	A$0.02
Shares out	228M
P/E (trailing)	22.6x
P/E (forward)	22.5x
Volume	222,218
Beta	0.96

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 23.9M
Net income (ttm): 3.6M
EPS (ttm): A$0.02
P/E (trailing): 22.6x
P/E (forward): 22.5x
Market cap: 82.1M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 13:30 UTC

Forward P/E22.5

P25 n/aP50 n/aP75 n/a

Trailing P/E22.6

P25 n/aP50 n/aP75 n/a

ROE51.3

P25 n/aP50 n/aP75 n/a

ROIC3.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ASX/BIO indicators

Market & fundamental data

Available fields

207

Groups with data

Currency

AUD

Showing 207 of 207 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-11-20
Employees	30
Employees change	0
Employees growth	0%
Enterprise value	AUD 81.5M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	2018
Industry	Packaged Foods
Is primary listing	Yes
ISIN number	AU0000184137
Last earnings date	2026-07-29
Last refreshed	2026-10-29
Market cap	AUD 82.1M
Next earnings date	2026-11-20
Price	AUD 0.36
Price currency	AUD
Sector	Consumer Staples
SIC code	2833
Stock price date	2026-10-29
Symbol	asx/BIO
Website	https://www.biomeaustralia.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	22.64x
Earnings yield	4.42%
EV/Earnings	22.59x
EV/EBIT	139.84x
EV/EBITDA	87.16x
EV/FCF	57.29x
EV/Sales	3.41x
FCF / EV yield	1.75%
FCF yield	1.73%
Forward P/E	22.5x
Graham number	0.12131
Graham upside	-66.3%
Industry forward P/E	15.89x
P/(FCF - SBC) ratio	76.28x
P/(OCF - SBC) ratio	64.1x
P/B ratio	8.75x
P/E ratio	22.64x
P/FCF ratio	57.7x
P/OCF ratio	50.45x
P/S ratio	3.44x
Price / tangible book value	9.19x
Price/EBITDA ratio	111.65x
Sector forward P/E	22.71x
Sector P/E	93.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	2.44%
EBITDA margin	3.08%
FCF margin	5.96%
Gross margin	57.45%
Operating margin	2.44%
Pretax margin	4.97%
Profit margin	15.11%
Profitable quarters	2
Profitable years	2
ROA	2.63%
ROA (5Y)	-19.07%
ROCE	5.68%
ROE	51.34%
ROE (5Y)	-33.48%
ROIC	3.62%
SBC / revenue	1.45%
Tax / revenue	-10.14%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	1,519.04%
EPS growth (QoQ)	105.37%
EPS growth quarters	2
EPS growth years	5
Gross profit growth	35.65%
Gross profit growth (Q)	30.48%
Gross profit growth 3Y	47.5%
Gross profit growth 5Y	63.37%
Net income growth	1,580.93%
Net income growth (QoQ)	106.65%
Net income growth quarters	2
Net income growth years	5
Revenue growth	29.68%
Revenue growth (Q)	20.21%
Revenue growth (QoQ)	-7.39%
Revenue growth 3Y	48.89%
Revenue growth 5Y	59.43%
Revenue growth quarters	14
Revenue growth years	7

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -204,376
Depreciation and amortization	AUD 152,385
EBIT	AUD 582,766
EBITDA	AUD 735,151
EPS	AUD 0.02
FCF per share	AUD 0.01
Financing cash flow	AUD -333,484
Free cash flow	AUD 1.4M
Free cash flow minus SBC	AUD 1.1M
Gross profit	AUD 13.7M
Income taxes	AUD -2.4M
Investing cash flow	AUD -488,706
Net borrowing	AUD -1.2M
Net cash flow	AUD 804,759
Net income	AUD 3.6M
Operating cash flow minus SBC	AUD 1.3M
Operating income	AUD 582,766
Revenue	AUD 23.9M
Stock-based compensation	AUD 346,508

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	9.55
Book value per share	AUD 0.04
Debt / EBITDA	3.17
Debt / equity	0.32
Debt / FCF	2.09
Interest coverage	5.09
Long-term assets	AUD 4.2M
Long-term liabilities	AUD 883,402
Net cash (debt)	AUD 583,199
Net cash / market cap	0.71%
Net debt / EBITDA	-0.79
Net debt / equity	-0.06
Net debt / FCF	-0.41
Piotroski F-Score	5
Property, plant and equipment	AUD 1.3M
Shareholders' equity	AUD 9.4M
Tangible book value	AUD 8.9M
Tangible book value per share	AUD 0.04
Total assets	AUD 15.7M
Total cash	AUD 3.6M
Total debt	AUD 3M
Total liabilities	AUD 6.3M
WACC	9.3%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.73
Current assets	AUD 11.6M
Current liabilities	AUD 5.5M
Current ratio	2.12
Inventory turnover	2.51
Net working capital	AUD 4.7M
Quick ratio	1.34
Working capital	AUD 6.1M
Working capital turnover	4.6

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-1.12%
Shareholder yield	-1.12%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	AUD 0.31
1D price change	-1.37%
1M price change	-11.11%
1M total return	-11.11%
1W price change	-5.26%
1W total return	-5.26%
1Y price change	-21.74%
1Y return CAGR	-21.75%
1Y total return	-21.74%
20-day SMA	AUD 0.39
200-day SMA	AUD 0.34
3M price change	35.85%
3M total return	35.85%
3Y price change	176.92%
3Y return CAGR	40.42%
3Y total return	176.92%
50-day SMA	AUD 0.37
50-day SMA vs 200-day SMA	50over200
52-week high	AUD 0.49
52-week high date	2026-02-04
52-week low	AUD 0.20
52-week low date	2026-06-02
6M price change	18.03%
6M total return	18.03%
All-time high	AUD 0.87
All-time high date	2024-09-20
All-time low	AUD 0.06
All-time low date	2023-06-08
Average true range (ATR)	AUD 0.02
Average volume	124.6K
Beta (1Y)	0.8
Beta (2Y)	1.07
Beta (5Y)	0.96
Change from 52-week high	-26.53%
Change from 52-week low	80%
Change from all-time high	-58.62%
Change from all-time low	500%
Change from open	-1.37%
Day's gap	0%
Dollar volume	AUD 79,998
High price	AUD 0.37
Low price	AUD 0.36
Monthly RSI	48.17
Open price	AUD 0.37
Position in 52-week range	33.33%
Previous close	AUD 0.37
Price vs 150-day SMA	15.02%
Price vs 20-day SMA	-7.76%
Price vs 200-day SMA	6.73%
Price vs 50-day SMA	-3.79%
Relative volume	1.78
RSI	41.23
Sharpe ratio	-0.13
Sharpe ratio (3Y)	0.76
Sortino ratio	-0.11
Sortino ratio (3Y)	1.37
Volume	222.2K
Weekly RSI	52.06
YTD price change	-14.29%
YTD total return	-14.29%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	162.2M
Shares change (QoQ)	0.81%
Shares change (YoY)	1.12%
Shares held by insiders	21.94%
Shares held by institutions	1.06%
Shares outstanding	228M

Deeper analysis on ASX/BIO

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/BIO report

Is a complete ASX/BIO research report available?

No complete published report is available for asx/BIO (ASX/BIO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/BIO (ASX/BIO)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/BIO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/BIO indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/BIO

Frequently asked questions